Erlotinib Hydrochloride Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report ID: 2663 | Published Date: Oct 2024 | No. of Page: 143 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL ERLOTINIB HYDROCHLORIDE INDUSTRY
    2.1 Summary about Erlotinib Hydrochloride Industry
    2.2 Erlotinib Hydrochloride Market Trends
        2.2.1 Erlotinib Hydrochloride Production & Consumption Trends
        2.2.2 Erlotinib Hydrochloride Demand Structure Trends
    2.3 Erlotinib Hydrochloride Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 25mg
        4.2.2 100mg
        4.2.3 150mg
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Non-small Cell Lung Cancer
        4.3.2 Pancreatic Cancer
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 25mg
        5.2.2 100mg
        5.2.3 150mg
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Non-small Cell Lung Cancer
        5.3.2 Pancreatic Cancer
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 25mg
        6.2.2 100mg
        6.2.3 150mg
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Non-small Cell Lung Cancer
        6.3.2 Pancreatic Cancer
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 25mg
        7.2.2 100mg
        7.2.3 150mg
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Non-small Cell Lung Cancer
        7.3.2 Pancreatic Cancer
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 25mg
        8.2.2 100mg
        8.2.3 150mg
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Non-small Cell Lung Cancer
        8.3.2 Pancreatic Cancer
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 25mg
        9.2.2 100mg
        9.2.3 150mg
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Non-small Cell Lung Cancer
        9.3.2 Pancreatic Cancer
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Roche
        10.1.2 Cipla
        10.1.3 Mylan
        10.1.4 Teva
        10.1.5 OSI Pharmaceuticals
        10.1.6 Glenmark Pharmaceuticals
        10.1.7 Beacon Pharmaceuticals
        10.1.8 Raichem Lifesciences
        10.1.9 United Biotech
        10.1.10 CJ Corporation
        10.1.11 Vivimed Labs
        10.1.12 Boryung Pharmaceutical
        10.1.13 Taj Pharmaceuticals
        10.1.14 Pharmascience
        10.1.15 Natco Pharma
        10.1.16 Intas Pharmaceuticals
        10.1.17 RPG Life Sciences
        10.1.18 Pharmascience
        10.1.19 Schwarz Pharma
        10.1.20 Dr. Reddy’s Laboratories
        10.1.21 Glenmark Pharmaceuticals
        10.1.22 Chugai Pharmaceutical
        10.1.23 DKSH
        10.1.24 Firma Chun Cheong
        10.1.25 Kremers Urban Pharmaceuticals
        10.1.26 Ortat
        10.1.27 Zuellig Pharma
    10.2  Erlotinib Hydrochloride Sales Date of Major Players (2017-2020e)
        10.2.1 Roche
        10.2.2 Cipla
        10.2.3 Mylan
        10.2.4 Teva
        10.2.5 OSI Pharmaceuticals
        10.2.6 Glenmark Pharmaceuticals
        10.2.7 Beacon Pharmaceuticals
        10.2.8 Raichem Lifesciences
        10.2.9 United Biotech
        10.2.10 CJ Corporation
        10.2.11 Vivimed Labs
        10.2.12 Boryung Pharmaceutical
        10.2.13 Taj Pharmaceuticals
        10.2.14 Pharmascience
        10.2.15 Natco Pharma
        10.2.16 Intas Pharmaceuticals
        10.2.17 RPG Life Sciences
        10.2.18 Pharmascience
        10.2.19 Schwarz Pharma
        10.2.20 Dr. Reddy’s Laboratories
        10.2.21 Glenmark Pharmaceuticals
        10.2.22 Chugai Pharmaceutical
        10.2.23 DKSH
        10.2.24 Firma Chun Cheong
        10.2.25 Kremers Urban Pharmaceuticals
        10.2.26 Ortat
        10.2.27 Zuellig Pharma
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT
List of Table
1.Table Erlotinib Hydrochloride Product Type Overview
2.Table Erlotinib Hydrochloride Product Type Market Share List
3.Table Erlotinib Hydrochloride Product Type of Major Players
4.Table Brief Introduction of Roche
5.Table Brief Introduction of Cipla
6.Table Brief Introduction of Mylan
7.Table Brief Introduction of Teva
8.Table Brief Introduction of OSI Pharmaceuticals
9.Table Brief Introduction of Glenmark Pharmaceuticals
10.Table Brief Introduction of Beacon Pharmaceuticals
11.Table Brief Introduction of Raichem Lifesciences
12.Table Brief Introduction of United Biotech
13.Table Brief Introduction of CJ Corporation
14.Table Brief Introduction of Vivimed Labs
15.Table Brief Introduction of Boryung Pharmaceutical
16.Table Brief Introduction of Taj Pharmaceuticals
17.Table Brief Introduction of Pharmascience
18.Table Brief Introduction of Natco Pharma
19.Table Brief Introduction of Intas Pharmaceuticals
20.Table Brief Introduction of RPG Life Sciences
21.Table Brief Introduction of Pharmascience
22.Table Brief Introduction of Schwarz Pharma
23.Table Brief Introduction of Dr. Reddy’s Laboratories
24.Table Brief Introduction of Glenmark Pharmaceuticals
25.Table Brief Introduction of Chugai Pharmaceutical
26.Table Brief Introduction of DKSH
27.Table Brief Introduction of Firma Chun Cheong
28.Table Brief Introduction of Kremers Urban Pharmaceuticals
29.Table Brief Introduction of Ortat
30.Table Brief Introduction of Zuellig Pharma
31.Table Products & Services of Roche
32.Table Products & Services of Cipla
33.Table Products & Services of Mylan
34.Table Products & Services of Teva
35.Table Products & Services of OSI Pharmaceuticals
36.Table Products & Services of Glenmark Pharmaceuticals
37.Table Products & Services of Beacon Pharmaceuticals
38.Table Products & Services of Raichem Lifesciences
39.Table Products & Services of United Biotech
40.Table Products & Services of CJ Corporation
41.Table Products & Services of Vivimed Labs
42.Table Products & Services of Boryung Pharmaceutical
43.Table Products & Services of Taj Pharmaceuticals
44.Table Products & Services of Pharmascience
45.Table Products & Services of Natco Pharma
46.Table Products & Services of Intas Pharmaceuticals
47.Table Products & Services of RPG Life Sciences
48.Table Products & Services of Pharmascience
49.Table Products & Services of Schwarz Pharma
50.Table Products & Services of Dr. Reddy’s Laboratories
51.Table Products & Services of Glenmark Pharmaceuticals
52.Table Products & Services of Chugai Pharmaceutical
53.Table Products & Services of DKSH
54.Table Products & Services of Firma Chun Cheong
55.Table Products & Services of Kremers Urban Pharmaceuticals
56.Table Products & Services of Ortat
57.Table Products & Services of Zuellig Pharma
58.Table Market Distribution of Major Players
59.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
60.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
61.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) by Region 2021f-2026f
62.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) Share by Region 2021f-2026f
63.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) by Demand 2021f-2026f
64.Table Global Erlotinib Hydrochloride Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Erlotinib Hydrochloride Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Erlotinib Hydrochloride Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Erlotinib Hydrochloride Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Erlotinib Hydrochloride Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Erlotinib Hydrochloride Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Erlotinib Hydrochloride Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Erlotinib Hydrochloride Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure 25mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure 150mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Non-small Cell Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure 25mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure 150mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Non-small Cell Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure 25mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure 150mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Non-small Cell Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure 25mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure 150mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Non-small Cell Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure 25mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure 150mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Non-small Cell Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure 25mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure 100mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure 150mg Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Non-small Cell Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Roche 2017-2020e
66.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Cipla 2017-2020e
67.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Mylan 2017-2020e
68.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Teva 2017-2020e
69.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of OSI Pharmaceuticals 2017-2020e
70.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Glenmark Pharmaceuticals 2017-2020e
71.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Beacon Pharmaceuticals 2017-2020e
72.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Raichem Lifesciences 2017-2020e
73.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of United Biotech 2017-2020e
74.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of CJ Corporation 2017-2020e
75.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Vivimed Labs 2017-2020e
76.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Boryung Pharmaceutical 2017-2020e
77.Figure Erlotinib Hydrochloride Sales Revenue (Million USD) of Taj Pharmaceuticals 2017-2020e
78.Figure Erlotinib Hydrochloride Sales Rev
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Erlotinib Hydrochloride Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erlotinib Hydrochloride Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erlotinib Hydrochloride Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports